People News: Roche NimbleGen and ISI

Share this article:
Roche NimbleGen named Frank Pitzer CEO. Dr. Pitzer was previously head of divisional quality and regulatory affairs at Roche Diagnostics, reporting directly to the CEO, and was also a member of the Diagnostics executive committee.

ISI, a life sciences software company, named Lisa Jenkins, PhD director of regulatory strategy, responsible for advising clients on clinical development and global strategic regulatory affairs. Jenkins was previously associate director/regulatory group leader at Kendle International, and before that she was the principal statistician and senior manager of regulatory affairs at Wyeth.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions